BioMerieux SA Stock Xetra
Equities
EYW
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.25B | Sales 2025 * | 4.19B 4.57B | Capitalization | 11.19B 12.19B |
---|---|---|---|---|---|
Net income 2024 * | 463M 504M | Net income 2025 * | 526M 573M | EV / Sales 2024 * | 2.85 x |
Net cash position 2024 * | 89.37M 97.33M | Net cash position 2025 * | 397M 432M | EV / Sales 2025 * | 2.57 x |
P/E ratio 2024 * |
24.6
x | P/E ratio 2025 * |
21.7
x | Employees | - |
Yield 2024 * |
0.94% | Yield 2025 * |
1.09% | Free-Float | 36.23% |
Latest transcript on BioMerieux SA
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 48 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
1st Jan change | Capi. | |
---|---|---|
+99.39% | 8.57B | |
-21.23% | 6.67B | |
+8.59% | 5.83B | |
-22.19% | 3.55B | |
+6.24% | 2.55B | |
+35.32% | 2.34B | |
-7.91% | 2.32B | |
-69.64% | 2.03B | |
-18.50% | 1.59B |